Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.

Details

Language :

English

ISSN :

03445704

Volume :

68

Issue :

6

Database :

Complementary Index

Journal :

Cancer Chemotherapy & Pharmacology

Publication Type :

Academic Journal

Accession number :

104602455